RegulatorySpine

Spine Pain Management Receives Notice of Allowance From U.S. Patent Office for Its Quad Video HALO(TM)

ORLANDO, Fla., April 9, 2015 (GLOBE NEWSWIRE) — Houston based Spine Pain Management, Inc. (OTCQB:SPIN), a technology-driven, medical service, device and healthcare solution company servicing the multi-billion dollar spine injury sector, is pleased to announce that its Quad Video HALO (QVH), a revolutionary video transparency accessory for medical fluoroscopy devices, has been issued a “Notice of Allowance,” allowing all claims, by the U.S. Patent and Trademark Office for Patent Application No. 13/723,372. Gleric Holdings, LLC, the assignee of the patent application, is a wholly-owned subsidiary of Spine Pain Management, Inc.

The QVH is the first device developed that has a clamp with an adjustable circumference that attaches to an X-ray head and includes mounts for accessories such as a camera, a video camera, a light fixture, a microphone, an image projector, a video projector, an imaging device, or a combination of these accessories. While the QVH includes a number of additional innovative features, the claims in the above mentioned patent application are directed to the novel adjustable clamp and accessory mount features.

Dr. William Donovan, CEO of Spine Pain Management said, “Over the last few years, SPIN has invested significant time and money in the development of the QVH, a proprietary real-time video and documentation accessory. The QVH has undergone rigorous testing and has been used to great success in conjunction with SPIN’s medical affiliates in a diagnostic program for treating more than a thousand spine injury cases. The QVH not only provides protection for the medical provider through secure video transparency and real-time documentation of the procedures, but also gives great comfort to the patient knowing his or her medical provider will ‘do his best’ in performing the procedure.” Donovan went on to say, “Some two years ago we realized the potential of the QVH and that with modifications, it could be expanded dramatically outside our own needs, not only for use with the tens of thousands of fluoroscopes (both fixed and portable) currently in service, but also in operating rooms world-wide. As a new player in the very competitive medical device and accessory space, we felt it was imperative to have a strong patent on the QVH before openly entering the market. Now with this patent, we feel we are ready to aggressively penetrate the market. Our patent attorney says ‘these claims will provide strong protection for our invention. The QVH will also be protected by additional patent applications that are currently in process.”

READ MORE HERE

Tags

Josh Sandberg

Josh Sandberg is the President of Ortho Sales Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close